Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor + HD-MTX + Rituximab + WBRT in CNS Lymphoma
NCT07002099Phase 2Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jun 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in central nervous system lymphoma, sponsored by The Second Affiliated Hospital of Soochow University. Started Jun 2025; status: recruiting.
02
Drugs
selinexor
03
Conditions
central nervous system lymphoma
Beyond the preview
Go deeper on NCT07002099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07002099.